Trials / Not Yet Recruiting
Not Yet RecruitingNCT07496645
EFFECT OF ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION ON NAMING IN APHASIC PATIENTS WITH ACUTE ISCHEMIC STROKE
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 28 (estimated)
- Sponsor
- Dr. Ram Manohar Lohia Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The use of transcranial direct current stimulation (tDCS) for the management of deficits developed in stroke is a relatively new type of management option. Many of the studies performed using tDCS have focused on improvements noted in hemiplegia as compared to aphasia, which is an equally disabling outcome of strokes. The results of these studies have not been conclusive and concordant with each other. In aphasia management, the majority of the studies have focused on chronic strokes. Since the use of tDCS is relatively new, the studies have not focused on a particular type of deficit or stroke. Very few studies have focused on the impact of solely using tDCS. Very few studies have focused on acute to subacute strokes. The results of the studies have, nevertheless, been encouraging. Improvements in aspects of language tested after a single session of tDCS are short-lived. There is an unmet need to probe the utility of repetitive tDCS on aspects of language function in patients who are aphasic due to acute stroke. There is also a paucity of data in the Indian scenario regarding the same.
Conditions
- Acute Ischemic Cerebrovascular Disease
- Post Stroke Aphasia
- Aphasia Following Cerebral Infarction
- Aphasia, Acquired
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcranial Direct Current Stimulation | Anodal tDCS |
| DEVICE | Transcranial Direct Current Stimulation | Sham tDCS |
Timeline
- Start date
- 2026-03-31
- Primary completion
- 2026-08-31
- Completion
- 2026-09-30
- First posted
- 2026-03-27
- Last updated
- 2026-03-27
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT07496645. Inclusion in this directory is not an endorsement.